Plain-language writing on ibogaine evidence, treatment access from Miami and the US, and the monitoring technology changing aftercare.
In August 2026 the University of Miami transferred its original 1994 ibogaine Investigational New Drug application to HHS — a landmark move that could accelerate federal ibogaine research.
Read articleA plain-language review of the current ibogaine evidence base: observational cohorts, cardiac safety data, and what ongoing trials may answer next.
Read articleIbogaine remains Schedule I in Florida and across the US. Here is how Miami-area patients actually access supervised treatment, and what to check before committing to any program.
Read articleHow the ibogaine.nz companion app extends clinical-grade cardiac and wellbeing monitoring into the recovery window — and why that window is where outcomes are decided.
Read article